Medrol and Malignant neoplasm progression - a phase IV clinical study of FDA data
Summary:
Malignant neoplasm progression is reported as a side effect among people who take Medrol (methylprednisolone), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Lung cancer - non-small cell.
The phase IV clinical study analyzes which people have Malignant neoplasm progression when taking Medrol. It is created by eHealthMe based on reports of 23,951 people who have side effects when taking Medrol from the FDA, and is updated regularly.
What is Medrol?
Medrol has active ingredients of methylprednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 24,443 Medrol users. Check the latest studies of Medrol.
What is Malignant neoplasm progression?
Malignant neoplasm progression (cancer tumour came back) is found to be associated with 1,511 drugs and 1,635 conditions by eHealthMe. Check the latest studies of Malignant neoplasm progression.
23,951 people reported to have side effects when taking Medrol.
Among them, 176 people (0.73%) have Malignant neoplasm progression.
Among these 176 people:
How long have people been on Medrol when they have Malignant neoplasm progression? *
What is the gender of people who have Malignant neoplasm progression when taking Medrol? *
What is the age of people who have Malignant neoplasm progression when taking Medrol? *
What are other drugs people take besides Medrol? *
What are other side effects people have besides Malignant neoplasm progression? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Medrol and have Malignant neoplasm progression?
- Check whether Malignant neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Medrol:
- Medrol (24,443 reports)
Malignant neoplasm progression treatments and more:
- Malignant neoplasm progression (107,528 reports)
How severe was Malignant neoplasm progression and when was it recovered:
Expand to all the drugs that have ingredients of methylprednisolone:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Medrol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,511 drugs)
Browse all the conditions that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,635 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on methylprednisolone (the active ingredients of Medrol) and Medrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Methotrexate Sodium cause Hospitalisation? - 4 seconds ago
- Drug interactions of Altace and Micronase - 7 seconds ago
- Could Sprycel cause Idiopathic Pulmonary Fibrosis? - 7 seconds ago
- Drug interactions of Sitagliptin Phosphate and Oxycodone - 10 seconds ago
- How effective is Mirtazapine for Dysthymia? - 11 seconds ago
- Anticoagulant Therapy and Diastolic Dysfunction - 13 seconds ago
- Drug interactions of Toradol and Sulfadiazine - 14 seconds ago
- Lung Cancer - Non-Small Cell and Pulmonary Embolism - 19 seconds ago
- Could Fentanyl Citrate cause Tricuspid Valve Incompetence? - 22 seconds ago
- Could Flonase cause Hyperkeratosis? - 23 seconds ago